ERIN ROBERTS: Open Payments
NPI 1942761382 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,566 in 139 payments from 20 companies in 2025. Trend: 2023 $2,115 · 2024 $3,187 · 2025 $2,566
Food & beverage: $2,566
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $739 |
| Aimmune Therapeutics, Inc. | 16 | $318 |
| Madrigal Pharmaceuticals | 11 | $281 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $243 |
| Janssen Biotech, Inc. | 8 | $161 |
| Regeneron Healthcare Solutions, Inc. | 5 | $158 |
| Ardelyx, Inc. | 6 | $131 |
| QOL Medical, LLC | 6 | $105 |
| Celltrion USA Inc. | 4 | $64 |
| Lilly USA, LLC | 4 | $63 |
Products named: ZENPEP, REZDIFFRA, RINVOQ, LINZESS, DUPIXENT, TREMFYA, IBSRELA, ENTYVIO.
Industry payments across MS — which companies pay providers there.
